IN8bio, Inc. (INAB) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IN8bio, Inc. on August 8, 2024. The filing primarily addresses two items: the announcement of financial results for the second quarter ended June 30, 2024, and a notification from Nasdaq regarding the company's failure to meet the minimum bid price requirement for continued listing.
Key Financial Metrics
The filing references a press release (Exhibit 99.1) containing the financial results for the quarter ended June 30, 2024. However, the text of this Form 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for these details.
Material Changes and Listing Status
On August 6, 2024, the company received notice from Nasdaq that its common stock closing bid price had been below $1.00 per share for 31 consecutive business days, violating Nasdaq Listing Rule 5450(a)(1). This is a material change in the company's listing status.
- Compliance Period: The company has 180 calendar days, until February 3, 2025, to regain compliance.
- Requirement: The closing bid price must be at least $1.00 per share for a minimum of ten consecutive business days prior to the compliance date.
- Consequences: Failure to comply may result in delisting, though the company may apply to transfer to the Nasdaq Capital Market or effect a reverse stock split.
Outlook, Risks, and Management Commentary
Management intends to actively monitor the stock price and evaluate options to resolve the deficiency, including a potential reverse stock split. The filing explicitly states that the information contained herein is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section. The primary risk identified is the potential delisting of the company's common stock if the minimum bid price requirement is not met by the compliance date.
Key Facts for Investor Verification
- Verify the specific Q2 2024 financial results (revenue, cash position, burn rate) in the press release attached as Exhibit 99.1, as they are not detailed in this 8-K text.
- Monitor the daily closing bid price of INAB stock to track progress toward the $1.00 threshold required for Nasdaq compliance.
- Watch for announcements regarding a potential reverse stock split or application to transfer listing to the Nasdaq Capital Market before February 3, 2025.
- Confirm whether the company has sufficient cash reserves to fund operations through the compliance period given the lack of revenue data in this filing.